Antibodies as delivery systems for diagnostic functions

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 63-80

  Khaw, Ban An ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute myocardial infarction; Anti atherosclerotic lesion specific antibody; Antifibrin antibody; Antimyosin antibody; Athersclerotic lesions; Cardiomyopathies; Charge modified antibodies; Imaging; Immunoscintigraphy; Monoclonal antibodies; Thrombosis

Indexed keywords

AGENTS; CARDIOLOGY; CARDIOVASCULAR SYSTEM; DIAGNOSTIC RADIOGRAPHY; IMMUNOLOGY; MEDICAL IMAGING; MONOCLONAL ANTIBODIES;

ACUTE MYOCARDIAL INFARCTION; ANTIATHEROSCLEROTIC LESION SPECIFIC ANTIBODY; ANTIFIBRIN ANTIBODY; ANTIMYOSIN ANTIBODY; ATHERSCLEROTIC LESIONS; CARDIOMYOPATHIES; CHARGE MODIFIED ANTIBODIES; DIAGNOSTIC FUNCTIONS; IMMUNOSCINTIGRAPHY; THROMBOSIS;

CONTROLLED DRUG DELIVERY;

ANTIBODY; DIAGNOSTIC AGENT; FIBRIN ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; INDIUM 111; IODINE 123; IODINE 131; MONOCLONAL ANTIBODY; MYOSIN ANTIBODY; RADIOISOTOPE; TECHNETIUM 99M;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CANCER; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; DIAGNOSTIC TEST; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ELECTRICITY; GRAFT REJECTION; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; IMAGING; IMMUNOSCINTIGRAPHY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOSIS; VASCULAR DISEASE;

EID: 0344958778     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00111-2     Document Type: Review

References (79)

1. P. Ehrlich, C.A. Herter, Ueber einige Verwendungen der Naphtochinonsulfosaure, Z. Physiol Chem. 61 (1904) 379-392.
2. D. Pressman, G. Keighley, Zone of activity of antibodies as determined by the use of radioactive tracers; sone of activity of nephrotoxic antikidney serum, J. Immunol. 59 (1948) 141-146.
3. P. Gold, J. Shuster, Historical development and potential uses of tumor antigens as markers of human cancer growth, Cancer Res. 40 (1980) 2973-2976.
4. G. Kohler, C. Milstein, Continuous cultures of fused cells secreting antibodies of predefined specificity, Nature (London) 256 (1975) 495-497.
5. J.-P. Mach, S. Carrel, M. Forni, J. Ritschard, A. Donath, P. Alberto, Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma, New Engl. J. Med. 303 (1980) 5-10.
6. D.M. Goldenberg, F.H. DeLand, E.E. Kim, F.J. Primus, J.R. van Nagell Jr., N. Estes, P. DeSimone, P. Rayburn, Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning, New Engl. J. Med. 298 (1978) 1384-1388.
7. I.P. Mach, F. Buchegger, M. Forni, et al., Use of radiolabeeld monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy, Immunol. Today 2 (1981) 239-247.
8. A. Bischof-Delaloye, B. Delaloye, F. Buchegger et al, Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study, J. Nucl. Med. 30 (1989) 1646-1656.
9. R.M. Rainsbury, J.H. Westwood, R.C. Coombes, et al., Localization of metastatic breast carcinoma by monoclonal antibody chelate labeled with In-111, Lancet 1 (1983) 934-938.
10. J.F. Chatal, J.C. Saccavii, P. Fumoleau, et al., Immunoscintigraphy of colon carcinoma, J. Nucl. Med. 25 (1984) 307-314.
11. E.L. Kramer, M.E. Noz, L. Liebes, S. Murthy, S. Tiu, D.M. Goldenberg, Radioimmunodetection of nonsmall cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab′ fragment. Preliminary results, Cancer 73(3 Suppl) (1994) 890-895.
12. A.A. Epenetos, J. Sheperd, K.B. Britton, et al., I-123 radioiodinated antibody imaging of occult ovarian cancer, Cancer 55 (1985) 984-987.
13. P.J. Babaian, L.M. Lamki, Radioimmunoscintigraphy of prostate cancrinoma, Semin. Nucl. Med. 19 (1989) 309-321.
14. S.M. Larson, J.A. Carrasquillo, K.A. Krohn, et al., Diagnostic imaging of malignant melanoma with radiolabeled anti-tumor antibodies, J. Am. Med. Assoc. 249 (1983) 811-812.
15. J.A. Carasquillo, J.L. Mulshine, B.A. Bunn, et al., Tumor imaging of In-111 T101 monoclonal antibody is superior to iodine-131 T101 in cutaneous T-cell lymphoma, J. Nucl. Med. 28 (1987) 281-287.
16. G. Mariani, N. Molea, D. Bacciardi, U. Boggi, G. Fornaciari, D. Campani, P.A. Salvadori, P.C. Giulianotti, F. Mosca, D.V. Gold, et al., Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancer, Cancer Res. 55(23) (1995) 5911-5915.
17. P. Peltier, C. Curtet, J.-F. Chatal, et al., Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/Anti-insium-DTPA antibody and an indium-111-labeled DTPA-dimer, J. Nucl. Med. 34 (1993) 1267-1273.
18. M.V. Pimm, H.F. Fells, A.C. Perkins, R.W. Baldwin, Iodine-131 and indium-111 labeled avidin and streptavidin for pretargeted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody, Nucl. Med. Commun. 9(11) (1988) 931-941.
19. S. Lastoria, E. Vergara, G. Palmieri, et al., In vivo detection of malignant thymic masses by In-111-DTPA-D-Phe-octreotide scintigraphy, J. Nucl. Med. 39 (1998) 634-639.
20. R.L. Wahi, L.E. Quint, R.L. Greenough, et al., Staging of mediastinal nonsmall cell lung cancer with F-FDG PET, CT, and fusion images: preliminary prospective evaluation, Radiology 191 (1994) 371-377.
21. B.A. Khaw, G.A. Beller, E. Haber, T.W. Smith, Localization of cardiac myosinspecific antibody in myocardial infarction, J. Clin. Invest. 58 (1976) 439-446.
22. T. Yasuda, I.F. Palacios, G.W. Dec, J.T. Fallon, H.K. Gold, R.C. Leinbach, H.W. Strauss, B.A. Khaw, E. Haber, Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis, Circulation 76 (1987) 306-311.
23. 111In monoclonal antimyosin, Am. J. Cardiol. 62 (1988) 623-627.
24. G.W. Dec, I. Palacios, T. Yasuda, J.T. Fallon, B.A. Khaw, H.W. Strauss, E. Haber, Antimyosin antibody cardiac imaging; its role in the diagnosis of myocarditis, Journal of the American College of Cardiology 16(1) (1990) 97-104.
25. M. Ballester, V. Marti, I. Carrió, et al., Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies, J. Am. Coll. Cardiol. 29(1) (1997) 160-167.
26. 111In-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer, J. Nucl. Med. 31 (1990) 1965-1969.
27. J. Narula, B.A. Khaw, J. Southern, in: B.A. Khaw, J. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Diseases, Lea and Febiger, Philadelphia, 1994, pp. 118-126.
28. L.C. Knight, Antifibrin antibody for detection of deep vwin thrombosis, in: B.A. Khaw, J. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Diseases, Lea and Febiger, Philadelphia. 1994, pp. 171-186.
29. J. Narula, C. Ditlow, F. Chen, B.A. Khaw, Monoclonal antibodies for detection of atherosclerotic lesions, in: B.A. Khaw, J. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Diseases, Lea and Febiger, Philadelphia, 1994, pp. 206-215.
30. K.J. Kairemo, T.A. Wikiund, K. Liewendahl, et al., Imaging of soft-tissue sarcomas with In-111-labeled monoclonal antimyosin Fab fragments, J. Nucl. Med. 31 (1990) 23-31.
31. R.C. Pasternak, E. Braunwald, Acute myocardial infarction, in: K.J. Isselbacher, E. Braunwald, B.D. Wilson, I.B. Martin, A.S. D.L. Fauci (Eds.), Harrison's Kasper Principles of Internal Medicine, McGraw-Hill Inc., New York, 13th ed. 1994, pp. 1066.
32. I.K. Bailey, L.S.C. Griffith, J. Rouleau, H.W. Strauss, B. Pitt, Thallium-201 myocardial perfusion imaging at rest and during exercise: Comparative sensitivity to electrocardiography in coronary artery disease, Circulation 55 (1977) 79-87.
33. B.A. Khaw, J. Scott, J.T. Fallon, E. Haber, C. Homey, Myocardial injury: Quantitation by cell sorting initiated with anti-myosin fluorescent spheres, Science 217 (1982) 1050-1053.
34. 2 fragments specific for cardiac myosin, Circulation 57 (1978) 743-750.
35. B.A. Khaw, T. Yasuda, H.K. Gold, R.C. Leinbach, J.A. Johns, M. Kanke, M. Barlai-Kovach, H.W. Strauss, E. Haber, Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab, J. Nucl. Med. 28 (1987) 1671-1678.
36. H. Berger, A. Lahiri, J. Leppo, T. Makler, J. Maddahi, G. Mintz, HW. Strauss, Antimyosin imaging in patients with ischemic chest pain: initial results of phase III multicenter trial, J. Nucl. Med. 28 (1988) 805.
37. N. Tamaki, T. Yamada, A. Matsumori, A. Yoshida, T. Fujita, H. Othani, Y. Watanabe, Y. Yonekura, K. Endo, J. Konishi, C. Kawai, Indium-111 labeled antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with Tc-pyrophosphate imaging, J. Nucl. Med. 31 (1990) 136-142.
38. 2 fragments, Circulation 58 (1978) 1137-1142.
39. B.A. Khaw, A. Petrov, J. Narula, Complementary roles of antibody affinity and specificity in in vivo diagnostic cardiovascular targeting: how specific is antimyosin for irreversible myocardial damage. J. Nucl. Cardiol. (in press).
40. M.A. Nedelman, D.J. Shealy, R. Boulin, E. Brunt, J.I. Seasholtz, L.E. Allen, J.E. McCartney, F.D. Warren, H. Oppermann, R.H.L. Pang, H.J. Berger, H.F. Weisman, Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant singlechain Fv: Evaluation in a canine model of acute myocardial infarction, J. Nucl. Med. 34 (1993) 234-241.
41. M.J. Calcutt, A.A. Komissarov, M.T. Marchbank, S.L. Deutscher, Analysis of a nucleic-acid-binding antibody fragment: Construction and characterization of heavy-chain complementarity-determining region switch variants, Gene 168(1) (1996) 9-14.
42. H.U. Saragovi, D. Fritzpatrick, A. Raktabutr, H. Nakanishi, M. Kahn, M.I. Greene, Design and synthesis of a mimetic from an antibody complementarity determining region, Science 253 (1991) 792-795.
43. R.H. Painter, M.H. Freedman, Isolation and characterization of electrophoretically homogenous rabbit antihapten antibody populations. II. Survey of the isoelectric properties of antihapten antibodies directed against charged and uncharged proteins, J. Biol. Chem. 246 (1971) 1742-1751.
44. F.C. Silva Filho, A.B.S. Santos, T.M.U. de Carvalho, W. de Souza, Surface charge of resident, elicited, and activated mouse peritoneal macrophages, J. Leuk. Biol. 41 (1987) 143-149.
45. J.E. Gallagher, G. George, A.R. Brody, Sialic acid mediates the initial binding of positively charged inorganic particles to alveolar macrophage membranes, Am. Rev. Resp. Dis. 135 (1987) 1345-1352.
46. A. Yanagisawa-Miwa, Y. Uchida, F. Nakamura, T. Tomaru, H. Kido, T. Kamijo, T. Sugimoto, K. Kaji, M. Utsuyama, C. Kurashima, H. Ito, Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor, Science 257 (1992) 1401-1403.
47. W.-C. Shen, H.J.-P. Ryser, Conjugation of poly-L-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins, Proc. Natl. Acad. Sci. 75 (1978) 1872-1876.
48. X. Gao, L. Huang, Cationic liposomes and polymers for gene transfer, J. Liposome Res. 3 (1993) 17-30.
49. V.P. Torchilin, A.L. Klibanov, N.D. Nossiff, M.A. Slinkin, H.W. Strauss, E. Haber, V.N. Smirnov, B.A. Khaw, Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: Major increases in polyvalent cation binding without loss of antigen binding, Hybridoma 6 (1987) 229-240.
50. B.A. Khaw, A. Klibanov, S.M. O'Donnell, T. Saito, N. Nossiff, M.A. Slinkin, T.B. Newell, H.W. Strauss, V.P. Torchilin, Gamma imaging with negatively-charge-modified monoclonal antibody: modification with synthetic polymers, J. Nucl. Med. 32 (1991) 1742-1751.
51. J. Narula, A. Petrov, C. Ditlow, K.Y. Pak, F.W. Chen, B.A. Khaw, Maximizing radiotracer delivery for scintigraphic localization of experimental atherosclerotic lesions with high-dose negative-charge-modified Z2D3 antibody, J. Nucl. Cardiol. 4 (1997) 226-233.
52. J. Narula, V.P. Torchilin, A. Petrov, S. Khaw, V.S. Trubetskoy, S.M. O'Donnell, N.D. Nossiff, B.A. Khaw, In vivo targeting of acute myocardial infarction with negative charge, polymer-modified antimyosin antibody: use of different cross-linkers, J. Nucl. Cardiol. 2 (1995) 26-34.
53. 2 in the detection of atherosclerotic plaques, J. Nucl. Med. 36(5) (1995) 133.
54. L.L. Johnson, D.W. Seldin, M.E. Tresgallo, K. Bhatia, R.A. Rodney, J.F. Gibbons, P.D. Esser, Right ventricular infarction and function from dual isotope indium-111-antimyosin/thauium-201 SPECT and gated blood pool scintigraphy, J. Nucl. Med. 32 (1991) 1018.
55. B. van Vlies, E.D. van Royen, C.A. Visser, N.G. Meyne, M.M. van Buul, R.T. Peter, A.J. Dunning, Frequency of myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery, Am. J. Cardiol. 66 (1990) 1191-1195.
56. L. Narula, B.A. Khaw, T. Yasuda, Antimyosin imaging for acute myocarditis, in: B.A. Khaw, L. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Diseases, Lea and Febiger, Philadepphia, 1994, pp. 67.
57. H.T. Aretz, M.E. Billingham, W.. Edwards, S.M. Factor, J.T. Fallon, J.J. Fenoglio, E.G.J.. Olsen, E.J. Schoen, Myocarditis: a histopathologic definition and classification, J. Cardiovasc. Pathol. 1 (1986) 3-14.
58. W. Frist, T. Yasuda, G. Segall, B.A. Khaw, H.W. Strauss, H.K. Gold, E. Stinson, P. Oyer, J. Baldwin, M. Billingham, R. McDougall, E. Haber, Noninvasive detection of human cardiac transplant rejection with 'In antimyosin (Fab) imaging', Circulation 76 (1987) 81-85.
59. M. Ballester, D. Obrador, I. Carrio, J.M. Caralps-Riera, Indium-111 monoclonal antimyosin antibody studies in the diagnosis of rejection and management of patients after heart transplantation, in: B.A. Khaw, L. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Disease, Lea and Febiger, Philadelphia, 1994, pp. 79-98.
60. M. Ballester, D. Obrador, I. Carrio, J.M. Caralps-Riera, Indium-111 monoclonal antimyosin antibody studies in the diagnosis of rejection and management of patients after heart transplantation, in: B.A. Khaw, L. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Diseases, Lea and Febiger, Philadelphia, 1994, pp. 81.
61. M. Ballester, D. Obrador, I. Carrio, C. Moya, J.M. Auge, R. Bordes, V. Marti, I. Bosch, L. Berna, M. Estorch, G. Pons, M.L. Camara, J.M. Padro, A. Aris, J.M. Caralps, Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection related complications after heart transplantation, Circulation 85 (1992) 61-68.
62. L.H. Chow, S.J. Radio, T.D. Sears, B.M. McManus, Insensitivity of right ventricular biopsy in the diagnosis of myocarditis, J. Am. Coll. Cardiol. 14 (1989) 915-920.
63. A.E. Becker, C.D. Heijmans, C.E. Essed, Chronic nonischemic heart disease and endomyocardial biopsies. Worth the extra? Eur. Heart J. 12 (1991) 218-223.
64. I. Carrio, Diagnosis of doxorubicin cardiotoxicity with indium-1111 antimyosin Fab, in: B.A. Khaw, J. Narula, H.W. Strauss (Eds.), Monoclonal Antibodies in Cardiovascular Diseases, Lea and Febiger, Philadelphia, 1994, pp. 99-108.
65. A. Malhotra, J. Narula, T. Yasuda, S.K. Reddy, P. Chopra, P.G. Gopinath, R. Tandon, M.L. Bhatia, H.W. Strauss, B.A. Khaw, E. Haber, Indium-111-monoclonal antimyosin antibody imaging for diagnosis of rheumatic myocarditis, J. Nucl. Med. 31 (1990) 841.
66. I. Casans, A. Villar, V. Almenar, A. Blanes, Lyme myocarditis diagnosis by indium-111 antimyosin antibody scintigraphy, Eur J. Nucl. Med. 15 (1989) 330-331.
67. 111In-labeled antimyosin in Churg-Strauss vasculitis with myocardial involvement, Nuklearmedizin 29 (1990) 177-179.
68. R.C. Hendel, S. Cohen, G. Aurigemma, S. Whitfield, S. Dalberg, L. Pape, J. Leppo, Focal myocardial injury following blunt chest trauma: a comparison of indium-111 antimyosin scintigraphy with other noninvasive methods, Am. Heart J. 123 (1992) 1208-1215.
69. I.L. Spar, R.L. Goodland, S.I. Schwartz, Detection of preformed venous thrombi in dogs by means of I-131-labeled antibodies to dog fibrinogen, Circ. Res. 17 (1965) 322-329.
70. K.Y. Hui, E. Haber, G.F. Matsueda, Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen, Science 222 (1983) 1129-1132.
71. 2-terminal region of fibrin, Mol. Immunol. 21 (1984) 89-94.
72. M. Kanke, G.R. Matsueda, H.W. Strauss, T. Yasuda, C.S. Liau, B.A. Khaw, Localization and visualization of pulmonary emboli with radiolabeled fibrin specific monoclonal antibody, J. Nucl. Med. 32 (1991) 1254-1260.
73. A.B. Roberts, A.M. Lees, R.S. Lees, H.W. Strauss, J.T. Fallon, J. Taveras, S. Kopiwoda, Selective accumulation of low density lipoproteins in damaged arterial wall, J. Lipid Res. 24 (1983) 1160-1167.
74. I. Virgolini, C. Muller, P. Fitscha, P. Chiba, H. Sinzinger, Radiolabeling autologous monocytes with In0111 oxine for reinjection in patients with atherosclerosis, Prog. Clin. Biol. Res. 355 (1989) 271-280.
75. D.C. Harrison, E. Calenoff, F. Chen, W. Parmley, B.A. Khaw, R. Ross, Plaque associated immune reactivity as a tool for the diagnosis and treatment of atherosclerosis. Proceedings of the American Clinical and Climatological Association, Trans. Am. Clin. Climatol. Assoc. 103 (1992) 210-217.
76. B.A. Khaw, E. Calenoff, F. Chen, S.M. O'Donnell, N.D. Nossiff, H.W. Strauss, Localization of experimental atherosclerotic lesion with monoclonal antibody Z2D3, J. Nucl. Med. 32(5) (1991) 1005.
77. J. Narula, A. Petrov, C. Bianchi, C.C. Ditlow, J. Dilley, I. Pieslak, F.W. Chen, V.P. Torchilin, B.A. Khaw, Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 antibody specific for the proliferating smooth muscle cells of human atheroma: imaging with conventional antibody and image enhancement with negative charge-modified antibody, Circulation 92 (1995) 474-484.
78. 2 imaging of proliferating smooth muscle cell in atherosclerotic lesions, J. Nucl. Med. 37(5) (1996) 49.
79. B.A. Khaw, I. Carrio, P.L. Pieri, J. Narula, Radionuclide imaging of the synthetic smooth muscle cell phenotype in experimental atherosclerotic lesions, Trends Cardiovasc. Med. 6 (1996) 226-232.